AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

DUKEMOUNT CAPITAL PLC

Regulatory Filings Jun 2, 2025

4974_rns_2025-06-02_c1793e5e-e919-4495-9e18-603f54694f2d.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0128L

Capai PLC

02 June 2025

2 June 2025

capAI plc

("capAI" or the "Company")

Interview with Professor Ronjon Nag and Richard Edwards

Following Strategic Alliance with R42

capAI plc (LSE: CPAI) is pleased to share an interview with Professor Ronjon Nag and Richard Edwards, hosted by StockBox, following the Company's recently announced strategic alliance ("Alliance") with Silicon Valley venture firm R42.

In the interview, Professor Nag and Richard Edwards speak positively about the Alliance and how it is instrumental in shaping capAI's three-pillar operating strategy: Identify, Incubate, and Invent. They also discuss how the partnership provides capAI with capital-efficient access to early-stage AI innovation , particularly in the areas of media and medicine.

As part of the conversation, Professor Nag demonstrates an AI-powered book generator ; an example of the types of high-impact, commercialisable tools under early review by the Alliance.

Watch the interview here:

https://www.youtube.com/watch?v=CJ3tzDUPBek

The interview will also be available at www.stockboxmedia.com and on X via @StockBoxMedia

Enquiries

Company:

capAI plc [email protected]

Broker Enquiries:

Peterhouse Capital Limited Tel: +44 (0) 207 469 0930

A purple and blue background with white text AI-generated content may be incorrect.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAUPUCWQUPAUBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.